Hep Web Exclusives
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hep Web Exclusives

November 25, 2015
Hepatitis C Initiative in Ryan White Clinics—Findings from a Special Program of National Significance
The Health Resources and Services Administration (HRSA) presented findings and lessons from a four-year demonstration project that supported 29 organizations implementing focused interventions designed to increase access to and completion of hepatitis C (HCV) treatment for people also living with HIV at ID Week, a leading forum for sharing infectious disease research and practice.
November 24, 2015
What the Heck are RAVs?
RAVs are resistance associated variants.  RAVs occur during (viral breakthrough) and after treatment (relapse) with direct acting antiviral medications (inhibitors—protease, polymerase, NS5A). 
November 23, 2015
Newly Diagnosed with HIV/Hepatitis C? Here’s How to Best Get Help
There is a new generation of addicts facing even bigger dangers than the general malaise drugs and/or alcohol eventually bring to the people who abuse them.
November 20, 2015
Reflections of a Hepatitis C Advocate
After three days of attending of activities and symposium sessions at the 2015 AASLD Liver Meeting, I was thoroughly exhausted.
November 19, 2015
Hepatitis C Resource Center Discusses Hepatitis C with Lucinda Porter, RN
I was a patient who was infected with hepatitis C in 1988, and I turned that into an opportunity to learn more about hepatitis C.
November 16, 2015
Open Enrollment for Obamacare and Medicare
This article gives important information about the various health insurance plans available during open enrollment
November 15, 2015
Fighting Fatigue
Hepatitis C and fatigue often go hand in hand. But you don’t have to take the symptoms lying down.
November 11, 2015
Hepatitis C Treatment is Finished, so Now What?
Dear Lucinda, I just finished hepatitis C treatment with ribavirin. Now that I have taken the last pill, I’d like to detox and speed the clearing of these drugs from my body.
November 09, 2015
Hepatitis C in Corrections: A New Resource for Incarcerated People
A disproportionate number of people with hepatitis C (HCV) in the U.S. are or have been inmates in jails and prisons. 
November 04, 2015
HCV Drugs
On September 17, 2015, Achillion announced the second part of their Phase 2 study (the PROXY study) of odalasvir (ACH-3102) and sofosbuvir to treat genotype 1.
November 02, 2015
The Dark Side of Letting Insurance Payers Dictate Hepatitis C Treatment
Imagine that you have a disease and you have two choices of treatment.

November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
September 2012
July 2012
April 2012
March 2012
January 2012
December 2011
November 2011
July 2011
November 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
September 2009
September 2007


Current Issue
Hep Stories
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
• Hepatitis B
• Hepatitis C
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
Tell us what you think
Have you been diagnosed with liver fibrosis?

Hepatitis C Reader Survey
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.